31 (3), 564-579.e7
No clinically validated dosing regimen exists for BPC-157
Preclinical Research in cells and animals, before trials in people
The pharmacokinetic barrier has recently been overcome with the synthesis of the orally active, blood-brain barrierpermeable analog N-hexanoic-tyrosine-isoleucine-(6) aminohexanoic amide (dihexa)
Seth, R., Yang, S., Choi, S., Sabean, M
[14] By injecting hydroxocobalamin, vitamin B levels can be restored, helping to resolve anemia, fatigue, neurological symptoms, and other complications of B deficiency